Hamartomas represent localized overgrowth of cells in the parts which are normally associated with polyps, ie. mesenhimal, stromal, endodermal and ectodermal elements. Hamartomatous polyposis syndromes carry a significant risk of developing dysplasia, adenomas, gastrointestinal carcinomas, and pancreatic carcinomas. These syndromes may be classified on the basis of whether they represent hereditary syndromes or whether they occur on a sporadic basis. An overlap has been noticed among some of the syndromes. There have been described eight hereditary, and four non-hereditary hamartomatous poly pos syndromes. Hereditary syndromes include: Hereditary juvenile polyposis syndrome, Cowden syndrome, Bannayan-Ruvalcaba-Riley syndrome, Peutz-Jeghers syndrome, Nevus basal cell syndrome, Hereditary mixed polyposis syndrome, Neurofibromathosis type 1, and Multiple Endocrine Neoplasia type 2B. All of these syndromes are inherited in an autosomal dominant fashion. Non-hereditary syndromes include: Cronkhite-Canada syndrome, hyperplastic polyps, lymphoid polyposis, lymphomatous polyposis. The diagnosis of these syndromes primarily remains a clinical process. Treatment of these patients requires a coordinated multidisciplinary approach which includes gastroenterology, pathology, dermatology, surgery, oncology, and genetics.
Gammon A, Jasperson K, Kohlmann W, Burt RW. Hamartomatous polyposis syndromes. Best Pract Res Clin Gastroenterol. 2009;23:219–31.
2.
Lier MG, A W, EM MV, EJ K, EW S, Leerdam ME. High Cancer Risk in Peutz-Jeghers Syndrome: A Systematic Review and Surveillance Recommendations. Am J Gastro enterol. 2010;
3.
Kelly S, Dwerryhouse S, Safranek P, Hardwick R. Juvenile polyposis syndrome affecting the stomach: a case report. J Med Case Reports. 2008;2(314).
4.
Howe M, FA S, R.W. The risk of gastro intestinal carcinona in familial juvenile polyposis. Ann Surg Oncol. 1998;5:751–6.
5.
Inoue S, Matsumoto T, Iida M, Hoshika K, Shimizu M, Hisamoto N, et al. Juvenile polyposis occurring in hereditary hemorrhagic telangectasia. Am J Med Sci. 1999;317:59–62.
6.
Calva-Cerqueira D, Chinnathambi S, Pechman B, Bair J, Larsen-Haidle J, Howe. The rate of germline mu tations and large deletions of SMAD4 and BMPR1A in juvenile polyposis. Clin Genet. 2009;75:79–85.
7.
Salem OS, Steck WD. Cowden’s disease (multiple hamartoma and neoplasia syndrome): A case report and review of the English literature. J Am Acad Der matol. 1983;8:686–96.
8.
Gustafson S, Zbuk KM, Scacheri C, Eng C. Cowden syndrome 2007;34:428-34.
9.
Eng C. Will the real Cowden syndrome please stand up: Revised diagnostic criteria. J Med Genet. 2000;37:828–30.
10.
Marsh DJ, Kum JB, Lunetta KL, Bennett MJ, Gorlin RJ, Ahmed SF, et al. PTEN mutation spectrum and genotype - phenotype correlations in Bannayan - Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Human Molec Genet. 1999;8:1461–72.
11.
Kopacova M, Tacheci I, Rejchrt S, Bures J. Peutz-Jeg hers syndrome: diagnostic and therapeutic approach. World J Gastroenterol. 2009;15:5397–408.
12.
Schwarz RA. Basal cell nevus syndrome and gastro intestinal polyposis. N Engl J Med. 1978;299(49).
13.
Whitelaw SC, Murday VA, Tomlinson IP, Thomas HJ, Cottrell S, Ginsberg A, et al. Clinical and molecular features of the hereditary mixed polyposis syndrome. Gastro enterology. 1997;112:327–34.
14.
Satoh M, Wakabayashi O, Araya Y, Jinushi E, Yoshida F. Autopsy case of von Recklinghausen’s disease associated with lung cancer, gastrointestinal stromal tumor of the stomach, and duodenal carcinoid tumor. Nihon Kokyuki Gakkai Zasshi. 2009;47:798–804.
15.
Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF, et al. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. JAMA. 1996;276:1575–9.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
